Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Colonic Neoplasms × trastuzumab deruxtecan × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Neoplasm Metastasis 8 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Meningeal Carcinomatosis 1 HER2-mutant Non-Small Cell Lung Cancer 1 Gastrointestinal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Leucovorin 35 Fluorouracil 33 Oxaliplatin 31 Bevacizumab 29 Irinotecan 28 Cetuximab 21 Capecitabine 16 Panitumumab 13 IFL protocol 6 Folfox protocol 6 Nivolumab 5 Immunohistochemistry 5 pembrolizumab 4 Ramucirumab 4 Radiotherapy 4 Gene Expression Profiling 4 Floxuridine 4 dehydroftorafur 3 aflibercept 3 Surgical Procedures, Operative 3 Radiosurgery 3 Magnetic Resonance Spectroscopy 3 Ipilimumab 3 Gemcitabine 3 Fluorodeoxyglucose F18 3 Fentanyl 3 Drug Therapy 3 Chemotherapy, Adjuvant 3 Celecoxib 3 2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡